


Here at Odin Stem Cells, our groundbreaking work with Mesenchymal Stem Cells (MSCs) is opening new possibilities for those living with chronic pain. Join us as William shares how MSC therapy is changing the way we think about chronic pain treatment — offering hope for improved health, reduced complications, and a better quality of life. Webinar attendees will be the first to hear the latest research, patient success stories, and expert insights into this life-changing field.

Define what chronic pain is (beyond 3–6 months duration).
Common causes: arthritis, injuries, nerve damage, autoimmune conditions, etc.
The impact on quality of life, mental health, and daily function.
Standard care options (medications, injections, physical therapy, surgery).
Benefits but also limitations—masking symptoms vs. addressing underlying damage.
Why patients are seeking alternatives.


Standard care options (medications, injections, physical therapy, surgery).
Benefits but also limitations—masking symptoms vs. addressing underlying damage.
Why patients are seeking alternatives.

What Mesenchymal Stem Cells (MSCs) are and how they’re being studied.
Potential mechanisms: reducing inflammation, supporting tissue repair, promoting vascular health.
Research highlights, ongoing studies, and patient-reported outcomes.
Transparency: investigational status, not FDA-approved, but growing interest and evidence.
As you consider stem cell therapy for chronic pain, you likely have many questions and concerns. Our goal is to help you navigate through them, which is why we've compiled answers to the most common questions. Whether you need insights on MSC therapy, treatment options, or what to expect, our comprehensive FAQ section is here for you. If you don't find your question listed, feel free to ask us—we're here to assist you!
Mesenchymal Stem Cells are specialized cells that can help reduce inflammation and support tissue repair. When introduced to damaged areas, MSCs may promote healing by encouraging the body's natural regenerative processes and supporting vascular health.
MSC therapy for chronic pain is currently investigational and not yet FDA-approved. However, ongoing research and clinical studies are showing promising results, with growing interest from both the medical community and patients seeking alternatives to traditional pain management.
MSC therapy is being studied for various chronic pain conditions including arthritis, degenerative disc disease, joint injuries, nerve damage, and autoimmune-related pain. Research is ongoing to better understand its applications and effectiveness.
Results vary by individual and condition. Some patients report improvements within weeks, while others may notice gradual changes over 3-6 months as the regenerative process unfolds. William will discuss patient timelines and expectations during the webinar.
Unlike medications that mask symptoms, MSC therapy aims to address underlying tissue damage and inflammation. It offers a potential alternative for those who haven't found relief with conventional treatments or want to avoid long-term medication use or invasive surgery
